Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Hulk asked, "That’s something I’ve wondered

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155138
(Total Views: 749)
Posted On: 01/14/2022 4:48:42 PM
Posted By: Buddyboy20
Re: Hulk767 #115138
Hulk asked,

"That’s something I’ve wondered for a long time - if we all know the potential of the drug, and their business is finding the next great drug, why has no one stepped up? The answer many state is that we haven’t gotten a ‘reasonable” offer. Why not? In this frothy environment for pharma, why has no one come after one of the indications aggressively?"

Read More: https://investorshangout.com/post/view?id=632...z7Hz0Yoa6M

Ohm20 said,

"There are other drugs out there that will do one small part of what leronlimab will do. There is not another drug out there that covers so many indirect causes of illness in so many indications. That is because a disregulated immune system is responsible for so many of the causes and symptoms and CCR5 is a major controller of the immune system response."

Read More: https://investorshangout.com/post/view?id=6321980#Behavioral

To me, that is the major problem with the big pharmaceutical companies. Bringing Leronlimab into their pipeline, for any indication, would be disruptive to the rest of their pipeline. Once Leronlimab gets an approval, and becomes easily available, and the medical community becomes familiar with it, it's use has the potential to disrupt the entire concept of how drugs are developed and applied. It will force the medical community to look at immune system disregulation and inflammation as the underlying causes of many of our ailments.
In a perfect world, Leronlimab would be stocked in every emergency room, and pharmacy, in the world. It would/should be the first thing the doctor reaches for in many instances of medical need.
Would you bring in the one thing that could destroy the status quo, if your company was making billions by making the status quo? The status quo being, to make a little poison to treat a little bit of what ails you. Then, make a little more poison to treat the previous poisons.
IMHO


(8)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us